Impact of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside on cognitive deficits in animal models of Alzheimer’s disease: a systematic review

BACKGROUND: The efficacy of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside (TSG) treatment on cognitive decline in individuals with Alzheimer’s disease (AD) has not been investigated. Therefore, we systematically reviewed the effect of TSG on cognitive deficits in a rodent model of AD. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Chenxia, Peng, Weijun, Chen, Zeqi, Cao, Yucheng, Gong, Wei, Xia, Zi-an, Wang, Yang, Su, Nanxiang, Wang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002158/
https://www.ncbi.nlm.nih.gov/pubmed/27565551
http://dx.doi.org/10.1186/s12906-016-1313-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002158/
https://www.ncbi.nlm.nih.gov/pubmed/27565551
http://dx.doi.org/10.1186/s12906-016-1313-8

Ejemplares similares